<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30449493</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>19</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1879-3320</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>27</Volume>                    <Issue>4</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Dec</Month>                    </PubDate>                </JournalIssue>                <Title>Surgical oncology</Title>                <ISOAbbreviation>Surg Oncol</ISOAbbreviation>            </Journal>            <ArticleTitle>A scoring system to predict recurrence in breast cancer patients.</ArticleTitle>            <Pagination>                <MedlinePgn>681-687</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S0960-7404(18)30181-6</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.suronc.2018.09.005</ELocationID>            <Abstract>                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Current breast cancer recurrence prediction models have limitations for clinical practice (statistical methodology, simplicity and specific populations). We therefore developed a new model that overcomes these limitations.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">This cohort study comprised 272 patients with breast cancer followed between 2003 and 2016. The main variable was time-to-recurrence (locoregional and/or metastasis) and secondary variables were its risk factors: age, postmenopause, grade, oestrogen receptor, progesterone receptor, c-erbB2 status, stage, multicentricity, diagnosis and treatment. A Cox model to predict recurrence was estimated with the secondary variables, and this was adapted to a points system to predict risk at 5 and 10 years from diagnosis. The model was validated internally by bootstrapping, calculating the C statistic and smooth calibration (splines). The system was integrated into a mobile application for Android.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 272 patients with breast cancer, 47 (17.3%) developed recurrence in a mean time of 8.6 ± 3.5 years. The system variables were: age, grade, multicentricity and stage. Validation by bootstrapping showed good discrimination and calibration.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A points system has been developed to predict breast cancer recurrence at 5 and 10 years.</AbstractText>                <CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Paredes-Aracil</LastName>                    <ForeName>Esther</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>General Surgery Service, General University Hospital of Elda, Ctra Sax-La Torreta S/N, Elda, 03600, Alicante, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Palazón-Bru</LastName>                    <ForeName>Antonio</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Medicine, Miguel Hernández University, Ctra Valencia-Alicante S/N, San Juan de Alicante, Alicante, 03550, Spain. Electronic address: apalazon@umh.es.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Folgado-de la Rosa</LastName>                    <ForeName>David Manuel</ForeName>                    <Initials>DM</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Medicine, Miguel Hernández University, Ctra Valencia-Alicante S/N, San Juan de Alicante, Alicante, 03550, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ots-Gutiérrez</LastName>                    <ForeName>José Ramón</ForeName>                    <Initials>JR</Initials>                    <AffiliationInfo>                        <Affiliation>General Surgery Service, Marina Baixa Hospital, Avda Alcalde En Jaume Botella Mayor 7, Villajoyosa, 03570, Alicante, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Llorca-Ferrándiz</LastName>                    <ForeName>Cristina</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Oncology Service, General University Hospital of Elda, Ctra Sax-La Torreta S/N, Elda, Alicante, 03600, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Alonso-Hernández</LastName>                    <ForeName>Sonia</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Pathological Anatomy Service, General University Hospital of Elda, Ctra Sax-La Torreta S/N, Elda, Alicante, 03600, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Coloma-Lidón</LastName>                    <ForeName>José Vicente</ForeName>                    <Initials>JV</Initials>                    <AffiliationInfo>                        <Affiliation>General Surgery Service, General University Hospital of Elda, Ctra Sax-La Torreta S/N, Elda, 03600, Alicante, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gil-Guillén</LastName>                    <ForeName>Vicente Francisco</ForeName>                    <Initials>VF</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Medicine, Miguel Hernández University, Ctra Valencia-Alicante S/N, San Juan de Alicante, Alicante, 03550, Spain.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>18</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Netherlands</Country>            <MedlineTA>Surg Oncol</MedlineTA>            <NlmUniqueID>9208188</NlmUniqueID>            <ISSNLinking>0960-7404</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast neoplasms</Keyword>            <Keyword MajorTopicYN="N">Mobile applications</Keyword>            <Keyword MajorTopicYN="N">Models</Keyword>            <Keyword MajorTopicYN="N">Recurrence</Keyword>            <Keyword MajorTopicYN="N">Statistical</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>07</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>09</Month>                <Day>12</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>09</Month>                <Day>17</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>11</Month>                <Day>20</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>11</Month>                <Day>20</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>20</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30449493</ArticleId>            <ArticleId IdType="pii">S0960-7404(18)30181-6</ArticleId>            <ArticleId IdType="doi">10.1016/j.suronc.2018.09.005</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>